XIE/2:2026/Jan: Difference between revisions
(→1.28) |
(→1.28) |
||
| Line 58: | Line 58: | ||
#DoL = CDNA / CAb、 | #DoL = CDNA / CAb、 | ||
*L 光程 这里为 1;A280,A260 样品吸光度; | *L 光程 这里为 1;A280,A260 样品吸光度; | ||
CF_DNA,280·A260 “纯DNA”在同缓冲下测得的比值 A280/A260,用来估算DNA在280的交叉吸收; | *CF_DNA,280·A260 “纯DNA”在同缓冲下测得的比值 A280/A260,用来估算DNA在280的交叉吸收; | ||
εAb,280 抗体消光系数,本抗体为2.3865×10^5 M⁻¹·cm⁻¹; | *εAb,280 抗体消光系数,本抗体为2.3865×10^5 M⁻¹·cm⁻¹; | ||
εDNA,260 Oligo消光系数,该Oligo(TTTTCTCCTCTCTCCTCCTCTT,5'Azide)为 1.698×10^5 M⁻¹·cm⁻¹。 | *εDNA,260 Oligo消光系数,该Oligo(TTTTCTCCTCTCTCCTCCTCTT,5'Azide)为 1.698×10^5 M⁻¹·cm⁻¹。 | ||
===SDS-page验证偶联结果=== | ===SDS-page验证偶联结果=== | ||
Revision as of 12:55, 28 January 2026
1.13
Synthesis of Anti-Oligo
抗体还原
- 取2 ul(1mM) TCEP,用 PBS(7.4) 稀释至 20 ul(100uM),取 5 ul稀释后的 TCEP ,加入 85 ul PBS(7.40),涡旋混匀---TCEP溶液pH过低提前中和
- 取2 ul(50uM)抗体,用 PBS(pH 7.4)稀释至 10 ul(10uM),将 TECP 的 PBS 缓冲液加入其中,37℃ 孵育 2 h.
- 取1 ul(50uM)抗体,用 PBS(pH7.4)稀释至 8 ul,作为 C 组
偶联
- 将孵育好的溶液用 PBS(6.5) 洗涤4次(10000g 3.5min),均分样品(A.B)----buffer pH 6.5避免后续加入的Mal被水解(碱性易水解)
- A(共混组):向 A 中加入 5 ul(100uM) 的 Mal-PEg-DBCO 和 1 ul(1mM) Azide-ssDNA,室温避光孵育 4 h.
- B(依次组):1)向 B 中加入 5 ul(100uM) 的 Mal-PEg-DBCO,室温避光孵育 2 h. 2)孵育结束后,向其加入1 ul(1mM) Azide-ssDNA,室温避光孵育 2 h.
验证
- 强还原断开轻重链:向A、B、C中加入对应量的蛋白 loudingbuffer ,再各加入1 ulβ-巯基乙醇,100℃煮 10m in
- 10% SDS-Page.

1.19
incubation
- DNA samples were stratified by thiolation status into two primary groups: thiolated DNA (bearing a thiol modification) and non-thiolated DNA (without thiol modification). Within each primary group, samples were further subdivided by phosphate-buffered saline (PBS) pH, yielding subgroups at pH 5.5, 6.5, 6.7, 6.8, 7.0, 7.5, and 8.5. PBS solutions were prepared and adjusted to the target pH and verified with a calibrated pH meter at room temperature.
| S1 (100 μM) | S2 (100 μM) | TFO (100 μM) | Buffer |
|---|---|---|---|
| 2 μl | 2 μl | 2 μl | 194 μl |
FRET
- Method:Samples were measured in Cy3 and Cy5 channels using appropriate excitation/emission filters under constant instrument settings.

1.20
Antibody reduction
- Dilute 2 µL of antibody stock with 1× PBS to 10 µL (10 µM).
- Prepare a TCEP working solution by diluting 1.5 µL of 100 µM TCEP with 1× PBS to 90 µL.
- Mix the 10 µL antibody with 90 µL TCEP working solution and incubate at 37°C for 2.5 h (final antibody ≈1 µM; TCEP ≈1.5 molar equivalents).
- Purify the reduced antibody by three rounds of buffer exchange into 1× PBS.
Antibody functionalization with DBCO
- Add 5 µL of Mal‑PEG4‑DBCO (100 µM) to the purified, reduced antibody and incubate at 37°C for 2 h (5 eq).
Antibody conjugation to oligo
- Add 5 µL of Azide‑Oligo (100 µM) to the DBCO‑modified antibody and incubate at 37°C for 2 h to complete the strain‑promoted azide‑alkyne cycloaddition (SPAAC) coupling (5 eq).
Native-page
- Analyze reaction products by non‑denaturing electrophoresis using 7.5% native PAGE.
- Marker、Control(antibody)、Antibody-Oligo、Antibody-DNA、Marker

Conclusion :Nativepage is not a good chose antibody conjugation
1.21
Native-page
- Samples(1.20 antibody with oligo) and controls were analyzed by native polyacrylamide gel electrophoresis (PAGE) using a 3–5% stacking gel and a 12.5% resolving gel.
- Marker、Control(antibody)、Antibody-Oligo、Antibody-DNA、Marker

1.22
1.28
抗体偶联
平均偶联数量测量
- 双波长法计算标记度(Degree of Labeling, DoL)
以下公式采用 A280 和 A260 的吸光度值,通过校正 DNA 在 280 nm 处的贡献来计算抗体浓度、核酸浓度及最终的平均偶联数(DoL)。
- CAb = [A280 − CF_DNA,280·A260] / εAb,280·L
- CDNA = A260 / εDNA,260·L
- DoL = CDNA / CAb、
- L 光程 这里为 1;A280,A260 样品吸光度;
- CF_DNA,280·A260 “纯DNA”在同缓冲下测得的比值 A280/A260,用来估算DNA在280的交叉吸收;
- εAb,280 抗体消光系数,本抗体为2.3865×10^5 M⁻¹·cm⁻¹;
- εDNA,260 Oligo消光系数,该Oligo(TTTTCTCCTCTCTCCTCCTCTT,5'Azide)为 1.698×10^5 M⁻¹·cm⁻¹。